About this trial
Patients will undergo a combined rehabilitation treatment consisting of 15 sessions on Lokomat and 15 sessions of physical therapy over three weeks for a total of 30 sessions. Two sessions/day for 5 days a week. The same subjects will conduct clinical-functional assessments before, at the end of treatment, and after a 3-month follow-up:
3D Gait Analysis with defined protocol (BTSBioenginner); Spastic Paraplegia Rating Scale (SPRS); Six-Minute Walk Test (6MWT), Ten Meters Walk Test (10MWT), Gross Motor Function Measure-88 (GMFM-88) and Berg Balance Scale (BBS); Quality of life questionnaires: Medical Outcome Survey Short Form (SF-36) and ad hoc questionnaire for subjective assessment of symptoms during walking (HSP-SNAP).
This study is part of normal clinical practice and does not involve any changes to the current rehabilitation course for patients.
Eligibility criteria
Qualifiers
genetic or clinical diagnosis of HSP.
age greater than 4 years and less than 70
femur length > 23 cm
ability to walk independently indoors, with or without walking aids.
Disqualifiers
botulinum toxin injection or lower limb surgery in the previous 6 months
severe lower limb muscle retractions
severe osteoporosis
unhealed skin lesions in lower limbs
Trial design
Treatments tested in this trial
- Robot-Assisted Gait Training